ArticleCancers2020

MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer.

Alessandra Cataldo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.